menu
    • menu

    Company profile for IGC Pharma

    NEW Drugs in Dev: 5
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Strategic innovation is at the core of everything we do at IGC Pharma. From our pioneering scientific research to sustainable manufacturing practices and wide-reaching product development, the fabric of our company is woven together with innovative thinking applied to the science of hemp-derived cannabinoids. Since entering the cannabinoid research and development space in 2014, IGC’s house of brands has expanded from our si...
    Strategic innovation is at the core of everything we do at IGC Pharma. From our pioneering scientific research to sustainable manufacturing practices and wide-reaching product development, the fabric of our company is woven together with innovative thinking applied to the science of hemp-derived cannabinoids. Since entering the cannabinoid research and development space in 2014, IGC’s house of brands has expanded from our signature Hyalolex-Drops of Clarity™ to a line of affordable hemp-based therapeutic products.Our expertise in hemp science, research, product development, manufacturing, supply-chain management and corporate finance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IGC PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10224 Falls Road Potomac, MD 20854
    Telephone
    Telephone
    888.586.4421
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.igcpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IGC Pharma Expands CALMA Trial To Dominion Medical Associates
    IGC Pharma Expands CALMA Trial To Dominion Medical Associates

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/igc-pharma-expands-phase-2-calma-trial-with-new-clinical-site-at-dominion-medical-associates-a-ligh

    PHARMIWEB
    12 Jan 2026
    Share Share
    IGC Pharma Aligns FY to Calendar Year for Enhanced U.S. Reporting
    IGC Pharma Aligns FY to Calendar Year for Enhanced U.S. Reporting

    06 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharma-aligns-fiscal-year-with-calendar-year-to-enhance-u.s.-investor-transparenc-1124322

    ACCESSWIRE
    06 Jan 2026
    Share Share
    IGC Pharma Raises Capital To Advance IGC-AD1 Phase 2 Trial
    IGC Pharma Raises Capital To Advance IGC-AD1 Phase 2 Trial

    05 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-05/igc-pharma-raises-capital-to-advance-igc-ad1-phase-2-trial

    PHARMIWEB
    05 Jan 2026
    Share Share
    IGC Pharma Obtains New US Patent For Pharmaceutical Cannabinoids
    IGC Pharma Obtains New US Patent For Pharmaceutical Cannabinoids

    19 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-19/igc-pharma-secures-new-us-patent-as-pharmaceutical-cannabinoids-gain-regulatory-momentum

    PHARMIWEB
    19 Dec 2025
    Share Share
    IGC Pharma Benefits From Federal Shift To Schedule III
    IGC Pharma Benefits From Federal Shift To Schedule III

    15 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-15/igc-pharma-positions-as-a-singular-beneficiary-of-emerging-federal-momentum-toward-schedule-iii-cann

    PHARMIWEB
    15 Dec 2025
    Share Share
    Ascendiant Capital Raises IGC Pharma Price Target
    Ascendiant Capital Raises IGC Pharma Price Target

    10 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-10/igc-pharma-announces-coverage-report-by-ascendiant-capital-markets-about-the-reports-q2-results-we

    PHARMIWEB
    10 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search